mhurhangee/ep-ind-claims huggingface dataset:
An intermediate transfer member (1; 11) for use in a transfer-type image recording method including the steps of applying an ink to an intermediate transfer member to form an intermediate image and transferring the intermediate image to a recording medium, characterized in that a surface layer part of the intermediate transfer member (1; 11) comprises an organic siloxane compound having a siloxane bond and a polyalkylene oxide unit.
A middleware services layer for a platform system adapted to be incorporated in a mobile terminal for a wireless telecommunications system, said platform system including a mobile terminal platform assembly having a software services component, and application software loaded, installed and run in said mobile terminal platform assembly, characterized by at least one application programming interface, API, adapted to provide access to the mobile terminal platform assembly for loading, installing and running said application software in a plurality of application environments in said mobile terminal platform assembly, wherein the plurality of application environments includes a native and a non-native application environment; and in that the at least one API comprises: - a native API domain comprising a native environment management module for controlling applications in the native application environment; - a non-native API domain comprising a non-native environment manager module for controlling applications in the non-native application environment; - a Secure Access Manager module adapted to determine, based on credentials of a non-native application, whether said non-native application should be granted access to native services provided by the platform system; and - an Application Manager module adapted to intercept non-native applications and call on the secure access manager module to grant access for the non-native applications to native services provided by the platform system. - a native API domain comprising a native environment management module for controlling applications in the native application environment; - a non-native API domain comprising a non-native environment manager module for controlling applications in the non-native application environment; - a Secure Access Manager module adapted to determine, based on credentials of a non-native application, whether said non-native application should be granted access to native services provided by the platform system; and - an Application Manager module adapted to intercept non-native applications and call on the secure access manager module to grant access for the non-native applications to native services provided by the platform system.
A targeted retroviral vector particle for use in a method of inhibiting tumor metastasis, wherein each of the retroviral particles comprises: i) a modifed retroviral envelope protein wherein the retroviral envelope protein includes a receptor binding region which has been modified to contain a collagen binding domain comprising a peptide comprising the amino acid sequence Gly-His-Val-Gly-Trp-Arg-Glu-Pro-Ser-Phe-Met-Ala-Leu-Ser-Ala-Ala (SEQ ID NO:1), and ii) encodes a heterologous therapeutic polypeptide. wherein the targeted retroviral vector particles is to be intravenously administered to a human patient at a cumulative dose of at least 1.8 x 10 11 colony forming units (cfu). i) a modifed retroviral envelope protein wherein the retroviral envelope protein includes a receptor binding region which has been modified to contain a collagen binding domain comprising a peptide comprising the amino acid sequence Gly-His-Val-Gly-Trp-Arg-Glu-Pro-Ser-Phe-Met-Ala-Leu-Ser-Ala-Ala (SEQ ID NO:1), and ii) encodes a heterologous therapeutic polypeptide.
Movable loading and/or unloading device with at least one transport unit for moving the loading and/or unloading device with at least one storage unit fixed to the transport unit, on which at least one gripped object can be arranged or is arranged and has at least one manipulator unit fixed to the transport unit, which comprises of at least one, in particular multi-axis, manipulator which has at least one means of gripping for gripping the at least one gripped object and by means of which at least the one gripped object can be arranged and/or removed in a processing station, such as a machine tool, and/or in or on the storage unit, the storage unit having at least one holding means by which the at least one gripped object can be fixed against movement, at least transversely, or at an angle to the direction of travel of the loading and unloading device, characterised by at least one clamping element by which the gripped object can be fixed against movement parallel, transverse and oblique to the direction of travel and by at least one processing unit fixed on the transport unit, through which the at least one gripped object fixed to the clamping element can be processed.
A method of facilitating wireless communications, comprising: determining, at a control module of a base station (30, 32), a first portion of an uplink interference associated with a plurality of first users (22, 24, 26) controlled by a scheduler of the base station, based upon measurements from the plurality of first users that indicate a data-chip energy to total interference ratio E c /I o and a traffic to pilot ratio TPR; and determining, at said control module, a second portion of the uplink interference associated with a plurality of second users not controlled by the scheduler, based upon measurements from the plurality of second users that indicate a data-chip energy to total interference ratio E c /I o and traffic to pilot power ratio TPR; the first and second portion being determined by determining a plurality of first products E c /I o ∗TPR from the measurements from each of the first users; determining a first sum of the determined plurality of first products; determining a plurality of second products E c /I o ∗1, E c /I o ∗TPR from the measurements from each of the second users; determining a second sum of the determined plurality of second products; determining the first sum and the second sum, respectively, for each of a plurality of time intervals establishing a set of linear equations that includes at least the determined sums; and using the established set of linear equations for determining a value of the first and second portions of the uplink interference, respectively. determining, at a control module of a base station (30, 32), a first portion of an uplink interference associated with a plurality of first users (22, 24, 26) controlled by a scheduler of the base station, based upon measurements from the plurality of first users that indicate a data-chip energy to total interference ratio E c /I o and a traffic to pilot ratio TPR; and determining, at said control module, a second portion of the uplink interference associated with a plurality of second users not controlled by the scheduler, based upon measurements from the plurality of second users that indicate a data-chip energy to total interference ratio E c /I o and traffic to pilot power ratio TPR; the first and second portion being determined by determining a plurality of first products E c /I o ∗TPR from the measurements from each of the first users; determining a first sum of the determined plurality of first products; determining a plurality of second products E c /I o ∗1, E c /I o ∗TPR from the measurements from each of the second users; determining a second sum of the determined plurality of second products; determining the first sum and the second sum, respectively, for each of a plurality of time intervals establishing a set of linear equations that includes at least the determined sums; and using the established set of linear equations for determining a value of the first and second portions of the uplink interference, respectively.
Strip consisting of an aluminium material for production of components with high forming requirements, characterized in that the strip has a core layer of an AlMgSi alloy of alloy type AA6014, AA6016, AA6060, AA6111 or AA6181 and at least one external aluminium alloy layer arranged on one or both sides and made of a non-hardenable aluminium alloy, wherein the at least one external aluminium alloy layer consists of an aluminium alloy type AA8xxx or A1200, the at least one external aluminium alloy layer has a lower tensile strength than the core layer of an AlMgSi alloy of alloy type AA6014, AA6016, AA6060, AA6111 or AA6181 in state T4, wherein in state T4 the strip has a uniform elongation A g of more than 23% transverse to the rolling direction and with a thickness of 1.5 mm to 1.6 mm, a bend angle of less than 40° is achieved in the bending test transverse to the rolling direction.
Device for accommodating electronic assemblies, comprising a housing having at least one opening closable by means of a cover or a flap attached to the housing, and a mounting arranged in the housing, wherein the mounting at least has two slots for at least one assembly in each case, wherein the mounting is rotatably mounted and wherein for removing or inserting the assembly, the slots can be brought into alignment with the opening by rotating the mounting.
A non-volatile memory device suitable to be programmed in a sequential mode, the device including a plurality of blocks of memory cells each block of memory cells being for storing a word, each block being identified by an address, means for loading an input address at the beginning of a programming procedure and means (136,142) for setting an internal address to the input address, characterized in that the device further includes means for loading a predetermined number of input words in succession, means for latching a page consisting of the predetermined number of input words, means for executing a programming operation including writing the page in the blocks identified by consecutive addresses starting from the internal address, and means (139,142) for incrementing the internal address of the predetermined number in response to the completion of the programming operation.
A surgical access system comprising: an insufflating optical obturator comprising: a tubular obturator shaft having a longitudinal axis, a proximal end and a distal end; a tapered obturator tip disposed at the distal end of the shaft, the obturator tip having an inner surface that defines an inner contour and an outer surface that defines an outer contour, the obturator tip having a wall and a wall thickness defined between the inner surface and the outer surface, the wall of the obturator tip comprising a transparent material; and at least one vent hole disposed on the tip; and a handle disposed at the proximal end of the obturator shaft; a first laparoscope stop disposed on at least one of the inner surface of the obturator tip and an inner surface of the obturator shaft; and characterized in that in transverse cross-section of the inner surface of the tip, the tip has a generally rectangular cross-section having two oppositely disposed sides having a longer dimension interconnected by two oppositely disposed sides having a relatively shorter dimension and the shorter dimension of the generally rectangular inner surface of the obturator tip defines a second laparoscope stop, the insufflating optical obturator being configured to slidably receive a laparoscope into the obturator shaft which may be advanced to the first or second laparoscope stop. a tubular obturator shaft having a longitudinal axis, a proximal end and a distal end; a tapered obturator tip disposed at the distal end of the shaft, the obturator tip having an inner surface that defines an inner contour and an outer surface that defines an outer contour, the obturator tip having a wall and a wall thickness defined between the inner surface and the outer surface, the wall of the obturator tip comprising a transparent material; and at least one vent hole disposed on the tip; and a handle disposed at the proximal end of the obturator shaft; a first laparoscope stop disposed on at least one of the inner surface of the obturator tip and an inner surface of the obturator shaft; and characterized in that in transverse cross-section of the inner surface of the tip, the tip has a generally rectangular cross-section having two oppositely disposed sides having a longer dimension interconnected by two oppositely disposed sides having a relatively shorter dimension and the shorter dimension of the generally rectangular inner surface of the obturator tip defines a second laparoscope stop, the insufflating optical obturator being configured to slidably receive a laparoscope into the obturator shaft which may be advanced to the first or second laparoscope stop.
A process to form a LDPE, said process comprising polymerizing ethylene in the presence of at least one free-radical agent, and in the presence of a "metal alkyl-containing compound" wherein the metal is Al; wherein the free-radical agent is a peroxide; wherein the polymerization temperature is greater than, or equal to 180°C; wherein the LDPE has a density from 0.915 to 0.940 g/cc as measured in accordance with ASTM D792-08, Method B; and wherein the metal alkyl containing compound is present in an effective amount, greater than zero and less than 100 mole ppm metal, based on the total moles of ethylene added to the polymerization, wherein the "effective amount" is the level of aluminium required to increase the vinyl groups above that expected for the same polymer produced without any metal alkyl containing compound, as determined according to the method disclosed in the experimental part of this specification.
A high-moisture-content gummi candy having reduced syneresis and reduced surface stickiness, comprising: a gummi candy body; and a collagen casing coating and encapsulating the gummi candy body, wherein the gummi candy body contains 30% by weight to 75% by weight of a sugar, 0.5% by weight to 15% by weight of a gelling agent, and not less than 20% by weight of water and the gummi candy body has a moisture value of not lower than 20% by weight, a pH of not higher than 4.0, and a water activity value (measured as mentioned in the description) of not higher than 0.86. a gummi candy body; and a collagen casing coating and encapsulating the gummi candy body, wherein the gummi candy body contains 30% by weight to 75% by weight of a sugar, 0.5% by weight to 15% by weight of a gelling agent, and not less than 20% by weight of water and the gummi candy body has a moisture value of not lower than 20% by weight, a pH of not higher than 4.0, and a water activity value (measured as mentioned in the description) of not higher than 0.86.
A compound of formula: wherein R 14 is selected from the group consisting of -C -C 1-8 alkyl; -C -O-C 1-8 alkyl; -C 3-8 alkyl and -S 2 -C 1-8 alkyl; R 3 is H, C 1-5 alkyl, or a bond; R 4 is H, C 1-5 alkyl, or a bond; R 5 is H, a bond, or C 1-8 alkyl, wherein one methylene group optionally is replaced by -O-; R 6 is H, a bond, or C 1-8 alkyl, wherein one methylene group optionally is replaced by -O-; R 7 is H, a bond,-OH, or C 1-8 alkyl, wherein one or more methylene group optionally and individually is replaced by -O- and/or substituted with =O; R 8 is H, a bond, -OH, or C 1-8 alkyl, wherein one or more methylene group optionally and individually is replaced by -O- and/or substituted with =O; Anyone of R 3, R 4, R 5, R 6, R 7, and R 8 optionally is linked together to form a ring; A is a phenyl or a pyridinyl, wherein the phenyl or pyridinyl is optionally substituted with one or more substituents R 13 individually selected from the group consisting of halogen, -CX 3, -OCX 3, -CHX 2, -OCHX 2, -CH 2 X, -OCH 2 X, - CH 2 CX 3, OCH 2 CX 3, -C 1-8 alkyl, -OC 1-8 alkyl, -C 3-7 cycloalkyl, -OC 3-7 cycloalkyl, - CN, NO 2, -SO 2 CH 3, and -SF 5; and X is halogen; or a pharmaceutically acceptable salt thereof. R 14 is selected from the group consisting of -C -C 1-8 alkyl; -C -O-C 1-8 alkyl; -C 3-8 alkyl and -S 2 -C 1-8 alkyl; R 3 is H, C 1-5 alkyl, or a bond; R 4 is H, C 1-5 alkyl, or a bond; R 5 is H, a bond, or C 1-8 alkyl, wherein one methylene group optionally is replaced by -O-; R 6 is H, a bond, or C 1-8 alkyl, wherein one methylene group optionally is replaced by -O-; R 7 is H, a bond,-OH, or C 1-8 alkyl, wherein one or more methylene group optionally and individually is replaced by -O- and/or substituted with =O; R 8 is H, a bond, -OH, or C 1-8 alkyl, wherein one or more methylene group optionally and individually is replaced by -O- and/or substituted with =O; Anyone of R 3, R 4, R 5, R 6, R 7, and R 8 optionally is linked together to form a ring; A is a phenyl or a pyridinyl, wherein the phenyl or pyridinyl is optionally substituted with one or more substituents R 13 individually selected from the group consisting of halogen, -CX 3, -OCX 3, -CHX 2, -OCHX 2, -CH 2 X, -OCH 2 X, - CH 2 CX 3, OCH 2 CX 3, -C 1-8 alkyl, -OC 1-8 alkyl, -C 3-7 cycloalkyl, -OC 3-7 cycloalkyl, - CN, NO 2, -SO 2 CH 3, and -SF 5; and X is halogen; or a pharmaceutically acceptable salt thereof.
An image encoding method for encoding a pixel value of an encoding target by using a predicted value generated by means of spatial or temporal prediction using a previously-decoded image, the method comprising a step that performs prediction of the pixel value of the encoding target and obtains the predicted value; the method being characterized in that it further comprises: a step that computes data of a probability distribution which indicates what value an original pixel value has for the obtained predicted value, by shifting, in accordance with the predicted value, difference distribution data of a difference between the original pixel value and the predicted value in predictive encoding, where the difference distribution data is stored in advance; a step that clips the obtained data of the probability distribution so as to contain the data in a range from a lower limit to an upper limit for possible values of the original pixel value; a step that encodes the pixel value of the encoding target by using the clipped data of the probability distribution of the original pixel value from the lower limit to the upper limit. a step that computes data of a probability distribution which indicates what value an original pixel value has for the obtained predicted value, by shifting, in accordance with the predicted value, difference distribution data of a difference between the original pixel value and the predicted value in predictive encoding, where the difference distribution data is stored in advance; a step that clips the obtained data of the probability distribution so as to contain the data in a range from a lower limit to an upper limit for possible values of the original pixel value; a step that encodes the pixel value of the encoding target by using the clipped data of the probability distribution of the original pixel value from the lower limit to the upper limit.
A pharmaceutical composition comprising: i) a structurally constrained peptide of an HD2 domain of BCL9 (BCL9-HD2), comprising at least one hydrocarbon staple, or a pharmaceutically acceptable salt thereof, wherein the hydrocarbon staple is positioned so as to link a first BCL9-HD2 amino acid selected from the group consisting of Leu-351, Ser-352, Gln-353, Glu-354, Gln-355, Glu-357, His-358, Arg-359, Arg-361, Ser-362, Leu-363, Thr-365, Leu-366, Ile-369, Gln-370, Met-372, Nle-372, Leu-373, and Phe-374 with a second BCL9-HD2 amino acid selected from the group consisting of Leu-351, Ser-352, Gln-353, Glu-354, Gln-355, Leu-356, Glu-357, His-358, Arg-359, Glu-360, Arg-361, Ser-362, Leu-363, Gln-364, Thr-365, Leu-366, Arg-367, Asp-368, Ile-369, Gln-370, Arg-371, Met-372, Nle-372, Leu-373, and Phe-374, wherein the peptide comprises an interacting face comprised of amino acids that interact with β-catenin, wherein the interacting face comprises BCL9 residues Gln-355, His-358, Arg-359, Ser-362, Leu-363, Leu-366, Ile-369, Gln-370, Leu-373, and Phe-374 ii) one or more additional therapeutic agents for the prevention and/or treatment of cancer, and iii) a pharmaceutical carrier, adjuvant, or vehicle. i) a structurally constrained peptide of an HD2 domain of BCL9 (BCL9-HD2), comprising at least one hydrocarbon staple, or a pharmaceutically acceptable salt thereof, wherein the hydrocarbon staple is positioned so as to link a first BCL9-HD2 amino acid selected from the group consisting of Leu-351, Ser-352, Gln-353, Glu-354, Gln-355, Glu-357, His-358, Arg-359, Arg-361, Ser-362, Leu-363, Thr-365, Leu-366, Ile-369, Gln-370, Met-372, Nle-372, Leu-373, and Phe-374 with a second BCL9-HD2 amino acid selected from the group consisting of Leu-351, Ser-352, Gln-353, Glu-354, Gln-355, Leu-356, Glu-357, His-358, Arg-359, Glu-360, Arg-361, Ser-362, Leu-363, Gln-364, Thr-365, Leu-366, Arg-367, Asp-368, Ile-369, Gln-370, Arg-371, Met-372, Nle-372, Leu-373, and Phe-374, wherein the peptide comprises an interacting face comprised of amino acids that interact with β-catenin, wherein the interacting face comprises BCL9 residues Gln-355, His-358, Arg-359, Ser-362, Leu-363, Leu-366, Ile-369, Gln-370, Leu-373, and Phe-374 ii) one or more additional therapeutic agents for the prevention and/or treatment of cancer, and iii) a pharmaceutical carrier, adjuvant, or vehicle.
A battery system for a vehicle, comprising: a battery pack having a structure receiving at least one battery; at least one first sensor mounted to the structure for sensing an operating condition inside or outside of the structure; a safety module (24, 90) disposed on the structure, the safety module (24, 90) processing signals received from the at least one first sensor to identify if the operating condition defines an abnormal condition; and at least one second sensor sensing a condition of the battery pack and in communication with a vehicle battery management system, the safety module (24, 90) in communication with the BMS such that the condition of the battery pack is also communicated to the safety module (24, 90), characterized in that the structure includes a low point and includes a common pitch of the battery pack structure at a downward angle that aids in the flow of liquid to the low point, and the at least one first sensor defines a moisture sensor positioned at the low point. a battery pack having a structure receiving at least one battery; at least one first sensor mounted to the structure for sensing an operating condition inside or outside of the structure; a safety module (24, 90) disposed on the structure, the safety module (24, 90) processing signals received from the at least one first sensor to identify if the operating condition defines an abnormal condition; and at least one second sensor sensing a condition of the battery pack and in communication with a vehicle battery management system, the safety module (24, 90) in communication with the BMS such that the condition of the battery pack is also communicated to the safety module (24, 90), characterized in that the structure includes a low point and includes a common pitch of the battery pack structure at a downward angle that aids in the flow of liquid to the low point, and the at least one first sensor defines a moisture sensor positioned at the low point.
Method for testing a computer core in a computing unit having at least a first and a second computer core (2, 3), the computer cores (2, 3) being connected to one another via an internal connecting system of the computing unit and both computer cores (2, 3) contributing to the operating sequence of a motor vehicle, a test being carried out in the first computer core, while a program for carrying out the driving mode of the motor vehicle is simultaneously executed in the second computer core, for which purpose a test request is sent to both computer cores (2, 3), which test request ensures that a disruption in the operating sequence of the motor vehicle is minimized, after which, following the agreement of both computer cores (2, 3) to this test request, the first computer core is changed to a test mode and the second computer core applies test data to the first computer core and checks the correctness of the test results from the first computer core following the test run.